Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (62)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nagy, Z.P.
Right arrow Articles by Van Steirteghem, A.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagy, Z.P.
Right arrow Articles by Van Steirteghem, A.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. 7, pp. 1775-1780, 1995
© 1995 European Society of Human Reproduction and Embryology

research-article

Andrology: Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility

Z.P. Nagy1, G. Verheyen, J. Liu, H. Joris, C. Janssenswillen, A. Wisanto, P. Devroey and A.C. Van Steirteghem

Centre for Reproductive Medicine, University Hospital, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel) Laarbeeklaan 101, B-1090 Brussels, Belgium

Correspondence: 1To whom correspondence should be addressed

Antisperm antibodies present in the semen can be a primary cause of infertility. If the proportion of spermatozoa carrying antisperm antibodies is very high, then usually a poor result ensues in standard in-vitro fertilization. We therefore employed intracytoplasmic sperm injection (ICSI) in 55 cycles (37 patients) where the proportion of antisperm antibody-bound spermatozoa was 80% or higher, as determined by the mixed antiglobulin reaction (MAR) test. The type and location of antisperm antibodies were determined by the immunobead test in 30 of the 37 patients. The mean normal fertilization rate was 75.7% in these 55 cycles, which was significantly higher than the fertilization rate in another 1767 ICSI cycles (69.2%) performed over the same period and where MAR-negative semen (the level of antisperm antibodies was <80%) was used for microinjection. Embryonic development was comparable, but a higher proportion of poor-quality embryos was obtained with MAR-positive than with MAR-negative semen samples. Out of the 55 patients, 53 had embryos replaced (96.4%) and a fetal sac was detected by ultrasonography in 14 patients (26.4%). The data indicate that fertilization, embryo development and pregnancy rates after ICSI are not influenced significantly by the proportion of antisperm antibody-bound spermatozoa, nor by the dominant type of antibodies present, nor by the location of the antisperm antibody on the spermatozoa. The conclusion of this study is that ICSI should be the primary choice for patients who have high numbers of antisperm antibodies present in their semen.

Key words: antisperm antibody/fertilization/ICSI/immunological infertility/microinjection


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
N. Nikolettos, B. Asimakopoulos, and I. S. Papastefanou
Intracytoplasmic Sperm Injection-An Assisted Reproduction Technique That Should Make Us Cautious About Imprinting Deregulation
Reproductive Sciences, July 1, 2006; 13(5): 317 - 328.
[Abstract] [PDF]

Home page
 Hum Reprod UpdateHome page
P. Devroey and A. Van Steirteghem
A review of ten years experience of ICSI
Hum. Reprod. Update, January 1, 2004; 10(1): 19 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
V. Abdelmassih, J. P. Balmaceda, J. Tesarik, R. Abdelmassih, and Z. P. Nagy
Relationship between time period after vasectomy and the reproductive capacity of sperm obtained by epididymal aspiration
Hum. Reprod., March 1, 2002; 17(3): 736 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
G. Westlander, E. Ekerhovd, S. Granberg, N. Lycke, L. Nilsson, C. Werner, and C. Bergh
Serial ultrasonography, hormonal profile and antisperm antibody response after testicular sperm aspiration
Hum. Reprod., December 1, 2001; 16(12): 2621 - 2627.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Bohring, E. Krause, B. Habermann, and W. Krause
Isolation and identification of sperm membrane antigens recognized by antisperm antibodies, and their possible role in immunological infertility disease
Mol. Hum. Reprod., February 1, 2001; 7(2): 113 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Kamal, R. Mansour, I. Fahmy, G. Serour, C. Rhodes, and M. Aboulghar
Easily decapitated spermatozoa defect: a possible cause of unexplained infertility
Hum. Reprod., November 1, 1999; 14(11): 2791 - 2795.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Bronson
Detection of antisperm antibodies: an argument against therapeutic nihilism
Hum. Reprod., July 1, 1999; 14(7): 1671 - 1673.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.